On November 1, 2023, the Floating Population Service Center of the National Health Commission issued the "Notice on the Selected Technologies of the Technical Alternative Database of the National Health Technology Promotion and Application Information Service Platform", and the two innovative technologies of PMR pulsed magnetic microcirculation therapy system and ADD cognitive dysfunction screening system were selected into the technical alternative database of the National Health Technology Promotion and Application Information Service Platform.
The Floating Population Service Center of the National Health Commission is responsible for the construction and management of the national health technology promotion service system entrusted by the National Health Commission, the implementation of policies related to the promotion and application of health technology, and the selection and review of national health promotion and application technologies. The selection criteria for this candidate library are very strict, and it needs to pass the national expert review and technical review to confirm the feasibility, application prospects and market promotion of technological innovation. The selection of candidates is not only a high recognition of the application of functional medicine technology products by the state, but also a full affirmation of the innovative contributions made by Huisianpu in the field of early disease screening and chronic disease intervention and rehabilitation.
PMR Pulsed Magnetic Microcirculation Therapy System – focuses on the treatment of microcirculatory disorders
The PMR system applies the principle of bionic pulse magnetic resonance, combined with the ultra-low-frequency electromagnetic field introduction technology and the space electromagnetic field control technology, and emits extremely low-frequency electromagnetic signals to act on the human body. Under the action of the magnetic field, the atomic spin is changed to produce a new transmembrane potential on the basis of the original potential of the cell membrane, change the charge distribution on the surface of the membrane, restore the normal physiological state of red blood cells, correct the blood rheological indicators, reduce the aggregation of red blood cells, promote blood circulation, and then achieve the purpose of improving microcirculation abnormalities.
ADD Cognitive Dysfunction Screening System – focuses on early screening for Alzheimer's disease
The ADD system adopts international commonly used MMSE and ADL scales to output voice and images, record the patient's response, quickly count the test results, provide instant diagnostic data, and screen for cognitive dysfunction β α. The extraction of nonlinear feature quantities such as wavelet entropy realizes the selection of variable-scale features, and provides early evidence of cognitive dysfunction and AD for clinical practice.